Liu, H., Pedros, C., Kong, K., Canonigo-Balancio, A. J., Xue, W., & Altman, A. (2021). Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy. BMJ Publishing Group.
Cita Chicago Style (17a ed.)Liu, Hsin-Yu, Christophe Pedros, Kok-Fai Kong, Ann J. Canonigo-Balancio, Wen Xue, y Amnon Altman. Leveraging the Treg-intrinsic CTLA4–PKCη Signaling Pathway for Cancer Immunotherapy. BMJ Publishing Group, 2021.
Cita MLA (8a ed.)Liu, Hsin-Yu, et al. Leveraging the Treg-intrinsic CTLA4–PKCη Signaling Pathway for Cancer Immunotherapy. BMJ Publishing Group, 2021.
Precaución: Estas citas no son 100% exactas.